International Patent: INHIBITOR OF Z-ALPHA1-ANTITRYPSIN POLYMERIZATION TO TREAT ALPHA-1-ANTITRYPSIN (A1AT) DEFICIENCY IN SPECIFIC PATIENT POPULATIONS

GENEVA, June 19 -- BIOMARIN PHARMACEUTICAL INC. filed a patent application (US2025/055241) for “INHIBITOR OF Z-ALPHA1-ANTITRYPSIN POLYMERIZATION TO TREAT ALPHA-1-ANTITRYPSIN (A1AT) DEFICIENCY IN SPECIFIC PATIENT POPULATIONS”. With publication no. WO/2026/107132, here are the other details related to the patent application:

Kind: Initial Publication with ISR [A1]

IPC: A61K 31/404

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....